Figures computed from official regulatory filings — .
Analysttarget 4 USD (+239%) · consensus 4/5 · 1 buy · 0 hold · 0 sell
Ownershipinsiders 46% · institutions 4.31% · short 1.8% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Telomir Pharmaceuticals, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
3 buys2 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Whalen Matthew Pratt | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MacPherson Edward Clouston | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Del Giudice Matthew Paul | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Aminov Ereztrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Whalen Matthew Pratt | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Aminov Ereztrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| MacPherson Edward Clouston | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Del Giudice Matthew Paul | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| MacPherson Edward Clouston | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Aminov Ereztrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Del Giudice Matthew Paul | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Aminov Ereztrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Whalen Matthew Pratt | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Aminov Ereztrack record | Other | $10M | SEC |
| Aminov Ereztrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Aminov Ereztrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Aminov Ereztrack record | Sell | $1.2K | SEC |
| Aminov Ereztrack record | Sell | $1.2K | SEC |
| Bay Shore Trust | GiftD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Yanez Michelle | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Del Giudice Matthew Paul | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MacPherson Edward Clouston | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Whalen Matthew Pratt | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Jerman Michael Allen | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Aminov Ereztrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |